 |
|
| Blog results | Results 1 - 10 of about 350 for well differentiated neuroendocrine tumor. (0.27 seconds) |
| Sorted by relevance Sort by date |
| 19 Jun 2009 by Tiny Moderately Differentiated Neuroendocrine Carcinoma of the Larynx Well differentiated neuroendocrine carcinoma (typical carcinoid) is an extremely . Poorly differentiated or small cell neuroendocrine carcinoma is similar in . -> ... Fashion Resources - http://www.fashion-res.com/ [ More results from Fashion Resources ] |
| 5 Oct 2009 Well differentiated neuroendocrine tumors in disease progression. Exclusion Criteria: Well differentiated neuroendocrine tumors without disease progression; Patients with intolerance to somatostatin analogues ... Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r... [ More results from Clinical Trials Updates During the Last 7 Days ] |
| 20 Nov 2009 by M L A retrospective review suggest that a combination of T + C is active, well tolerated and may prolong survival and palliate symptoms in pts with neuroendocrine tumors. It is: Phase II Study of Capecitabine and Temozolomide for ... Cancer Treatment - http://cancertreatments.typepad.com/cancer_treatment/ - References |
| 20 Nov 2009 by admin A retrospective review suggest that a combination of T + C is active, well tolerated and may prolong survival and palliate symptoms in pts with neuroendocrine tumors, a malignancy closely relatd to islet cell (NET). ... Cancer Treatment Blog - http://www.cancertreatmentblog.com/ |
| 2 Nov 2009 by Chang Kyun Lee, Il-Kwun Chung, Suck-Ho... The pathological diagnoses were leiomyoma (7 of 15, 46.6%), GI stromal tumor (6 of 15, 40.0%), aberrant pancreas (1 of 15, 6.6%), and well-differentiated neuroendocrine carcinoma (1 of 15, 6.6%). Six cases with GI stromal tumor were ... Gastrointestinal Endoscopy - Articles in Press - http://www.giejournal.org/inpress?rss=yes |
| 19 Nov 2009 by salud equitativa Eriksson B, Kloppel G, Krenning E, Ahlman H, Plockinger U, Wiedenmann B, Arnold R, Auernhammer C, Korner M, Rindi G, Wildi S. Consensus guidelines for the management of patients with digestive neuroendocrine tumors--well-differentiated ... herenciageneticayenfermedad - http://herenciageneticayenfermedad.blogspot.com/ |
| 1 Sep 2009 by "Renal Carincoid Guy" available treatment options for patients with metastatic well-differentiated neuroendocrine tumors (low ki index) (nets) are associated with adverse events and reduced quality of life. octreotide lar, a somatostatin analog that is ... My journey thru Neuroendocrine Carcinoma... - http://www.renalcarcinoid.com/ |
| 9 Jul 2009 by tracey Octreotide LAR has previously been indicated for control of side effects of secretory neuroendocrine cancers, but this trial suggests an antitumor benefit for well-differentiated neuroendocrine tumors in general. ... CancerConsultants - http://www.cancerconsultants.com.php5-4.dfw1-1.websitetestlink.com/ |
| 11 Oct 2007 by Tad Kim, Stephen R Grobmyer, Chen Liu and... Our patient's clinical picture and above histopathologic findings are all consistent with the standard World Health Organization (WHO) classification of a well-differentiated gastroenteropancreatic neuroendocrine tumor of probable ... World Journal of Surgical Oncology - Latest... - http://www.wjso.com/ [ More results from World Journal of Surgical Oncology - Latest... ] |
| 2 Jun 2009 by Dr. NICK background:: beyond the usual regimens based on streptozocin and doxorubicin or 5-fluorouracil, no second-line therapy of metastatic neuroendocrine tumor has gained wide acceptance. gemcitabine and oxaliplatin are generally well ... CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/ [ More results from CANCER AND IMPORTANT MEDICAL NEWS ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
